Therapeutic Vaccination against T-Cell-Defined Tumor Antigens

Publisher： Karger

E-ISSN： 2296-5262|24|1|9-9

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.1, 2001-03, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Impaired CD8+ T-Cell Reactivity against Viral Antigens in Cancer Patients with Solid Tumors

By Trojan A.   Giger R.   Rist N.   Speck R.  

Infection, Vol. 32, Iss. 5, 2004-10 ,pp. : 287-292

Springer Publishing Company

Access to resources Recommend Favorite

Current Status of Dendritic Cell-Based Tumor Vaccination

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 544-551

Karger

Access to resources Recommend Favorite

Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1467-1479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV‐specific CD4+ T‐cell‐dependent natural killer cell effector responses in chronically infected rhesus macaques

By  

IMMUNOLOGY, Vol. 145, Iss. 2, 2015-06 ,pp. : 288-299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Cancer/Testis Tumor Associated Antigens in Cervical Squamous Cell Carcinoma

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 443-449

Karger

Access to resources Recommend Favorite